Torno Capital, LLC Vertex Pharmaceuticals Inc Transaction History
Torno Capital, LLC
- $624 Billion
- Q3 2024
A detailed history of Torno Capital, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Torno Capital, LLC holds 16,800 shares of VRTX stock, worth $7.82 Million. This represents 1.25% of its overall portfolio holdings.
Number of Shares
16,800
Previous 25,000
32.8%
Holding current value
$7.82 Million
Previous $11.7 Billion
33.32%
% of portfolio
1.25%
Previous 0.55%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,722Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$12.5 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$10.8 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.93 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.5 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$4.19 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...